News

Tackle Kids Cancer Receives $250,000 Gift from Sohn Conference Foundation to Benefit Pediatric Cancer and Patient Care at Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center Foundation is pleased to announce that Tackle Kids Cancer, a philanthropic initiative of the Children’s Cancer Institute at Hackensack Meridian Health which raises money for pediatric cancer research and patient care, has received a generous gift of $250,000 from Sohn Conference Foundation. This gift brings Sohn Conference Foundation’s lifetime giving to Hackensack University Medical Center to $2.5 million.

The donation will benefit Tackle Kids Cancer and its efforts to provide groundbreaking research initiatives and innovative patient care programs at the Children’s Cancer Institute at Hackensack Meridian Health. The gift also honors Tackle Kids Cancer as it approaches its fifth year milestone in combating pediatric cancer and its longstanding partnership with Sohn Conference Foundation.

For 25 years, Sohn Conference Foundation has supported initiatives to treat and cure pediatric cancer. Sohn Conference Foundation has been instrumental in growing the Cure and Beyond program at Hackensack University Medical Center. Cure and Beyond, led by program chief Michael Harris, M.D.,  provides long-term care to survivors of pediatric cancer and considers the ongoing physical and emotional needs in their recovery. It is the first comprehensive pediatric cancer survivorship program in the state.

In 2016, Sohn Conference Foundation and former New York Giants quarterback and Tackle Kids Cancer Team Captain Eli Manning launched the Sohn-Manning Pediatric Cancer Survivorship Program at Hackensack University Medical Center to benefit Cure and Beyond. Manning has been a powerful voice in support of Tackle Kids Cancer, and his work alongside Sohn Conference Foundation continues to benefit patients and families at the Children’s Cancer Institute.

Sohn Conference Foundation’s commitment to the fight against pediatric cancer will allow Tackle Kids Cancer to provide continuous support and resources to families experiencing pediatric cancer.

“Though the COVID-19 pandemic has been frightening, we understand that pediatric cancer patients must continue their critical care and treatment,” said Evan Sohn, co-founder, Sohn Conference Foundation. “My team – Chairman Graham Duncan, Chair Emeritus Daniel Hirsch, President Daniel Nir – and I are honored to make a donation to Tackle Kids Cancer in honor of Dr. Michael Harris and Eli Manning, who have been heroes for pediatric cancer, and all of the health care heroes who have worked tirelessly to care for pediatric cancer patients during this challenging time. Sohn Conference Foundation is privileged to have worked so closely with Hackensack University Medical Center for 25 years.”

“We are most grateful for Sohn Conference Foundation’s dedication to the fight against pediatric cancer,” said Helen A. Cunning, north regional president and chief development officer, Hackensack University Medical Center Foundation. “The long-term commitment of co-founder Evan Sohn and generosity of Sohn Conference Foundation is crucial to the vital work of the Children’s Cancer Institute at Hackensack Meridian Health, and we are proud to have their support.”

“The support of partners like Sohn Conference Foundation is essential to Tackle Kids Cancer’s work,” said Amy Glazer, executive director of development, Joseph M. Sanzari Children’s Hospital and Tackle Kids Cancer. “This gift allows Tackle Kids Cancer to continue providing compassionate, high-quality care to pediatric cancer survivors, and provide them with the resources to navigate life-long support and care.”

Since 2014, Tackle Kids Cancer has raised funds to support clinical and research programs at Hackensack Meridian Health’s Children’s Cancer Institute. Funds raised have allowed for the implementation of CAR-T cell therapy, the creation of comprehensive neuro-oncology programs, the establishment of a pain and palliative care program utilizing innovative technological intervention to help patients manage pain, and the development of a genomics and precision medicine program.